Login / Signup

A phase II study of carfilzomib in the treatment of relapsed/refractory mantle cell lymphoma.

Jee Hun LeeMaria BadilloJorge E RomagueraMichael Wang
Published in: British journal of haematology (2018)
Keyphrases
  • phase ii study
  • multiple myeloma
  • open label
  • acute lymphoblastic leukemia
  • locally advanced
  • acute myeloid leukemia
  • hodgkin lymphoma
  • clinical trial
  • squamous cell carcinoma
  • combination therapy
  • radiation therapy